-
Mashup Score: 2
Original Article from The New England Journal of Medicine — Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1A Community Practitioner and Policy Advocate Who Stresses Holistic, Patient-Centered Care - The ASCO Post - 3 year(s) ago
Kashyap Patel, MD Community practices have long been a keystone of our nation’s oncology care delivery system by allowing patients with cancer to receive specialized treatment near their homes and places of business. Innovative clinicians in the community setting are also leading efforts to create a more efficient and…
Source: ascopost.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1
More than 500 stakeholders sent comments to the FTC on whether the commission should look further into pharma middlemen, known as PBMs, with many of the commenters calling for more federal oversight. Similar to the critical open comment period in a deadlocked FTC session last February, pharmacies and pharmacy groups
Source: Endpoints NewsCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 9Women in Oncology Forum: Fireside Chat on Career Transitions - 4 year(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
United States House Committee on Oversight and Government Reform
Categories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1
Learn more at https://republicans-oversight.house.gov/
Source: YouTubeCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 9ASCO Plenary Series: November 2021 - 4 year(s) ago
Learn more about the faculty and program for the November Plenary Series session.
Source: ASCOCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0New mathematical modeling technique can accurately predict tumor response to chemotherapy - 4 year(s) ago
A public/private collaboration led by researchers at The University of Texas at Austin has resulted in a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy soon after treatment initiation.
Source: News-Medical.netCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1BreastCancerAwareness_30_Susan3_AU52989.mp4 | Powered by Box - 4 year(s) ago
Switch to the Accessible Version of Box ›BreastCancerAwareness_30_Susan3_AU52989.mp4Breast Cancer AwarenessSign upLog in Drop files on this page to upload them into this folder.
Source: tegna-corporate.app.box.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0- The Washington Post - 4 year(s) ago
Please enable cookies on your web browser in order to continue. The new European data protection law requires us to inform you of the following before you use our website: We use cookies and other technologies to customize your experience, perform analytics and deliver personalized advertising on our sites, apps and newsletters and across the Internet based on your interests. By clicking…
Source: Washington PostCategories: Hem/Oncs, Latest HeadlinesTweet
Practice changing Monday morning! Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM @ASCO @TheUSONetwork @TexasOncology https://t.co/HskxWl8YKp